Radiolabeled Complex of Antimicrobial Peptides UBI29-41 and UBI18-35 Labeled with 99mTc for Differential Diagnosis of Bone Infection of the Limbs; Bulletin of Experimental Biology and Medicine; Vol. 170, iss. 4
| Parent link: | Bulletin of Experimental Biology and Medicine Vol. 170, iss. 4.— 2021.— [P. 415-419] |
|---|---|
| Údair chorparáideacha: | Национальный исследовательский Томский политехнический университет (ТПУ) Физико-технический институт (ФТИ) Лаборатория радиационного контроля № 31 (Лаборатория РК № 31), Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий Научно-исследовательский центр "Онкотераностика" |
| Rannpháirtithe: | Zavadovskaya V. D. Vera Dmitrievna, Larkina M. S. Mariya Sergeevna, Stasyuk (Stasiuk) E. S. Elena Sergeyevna, Zorkaltsev M. A. Maksim Aleksandrovich, Udodov V. D. Vladimir Dmitrievich, Ivanov V. V. Vladimir Vladimirovich, Shevtsova N. M. Nataljya Mikhaylovna, Rogov A. S. Alexander Sergeyevich, Lushchik A. Ya. Aleksandr Yakovlevich, Yantsevich A. V. Aleksey Viktorovich, Belousov M. V. Mikhail Valerievich, Baykov A. N. Aleksandr Nikolaevich, Skuridin V. S. Viktor Sergeyevich, Pershina A. G. Aleksandra Gennadievna |
| Achoimre: | Title screen We studied an original radiolabeled complex of antimicrobial peptides UBI29-41 and UBI18-35, ubiquicidin derivatives, for distinguishing between bacterial and aseptic inflammation. For radiolabeling of the peptides with technetium-99m, a bifunctional chelating agent succinimide-1-yl 6-(bis(pyridin-2-ylmethyl)amino)hexanoate was used. The obtained complexes 99mТс-DPAH-UBI29-41 and 99mТс-DPAH-UBI18-35 had radiolabeling yield >80% and radiochemical purity >96%. Accumulation of the complexes in the focus of bacterial inflammation in bone structures and the absence of this complex in the site of aseptic inflammation was confirmed in a rat model of traumatic osteomyelitis by single-photon emission computed tomography. Режим доступа: по договору с организацией-держателем ресурса |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
2021
|
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1007/s10517-021-05078-7 |
| Formáid: | Leictreonach Caibidil leabhair |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=664885 |
Míreanna comhchosúla
Радиохимический комплекс на основе меченных 99mТс антимикробных пептидов UBI29-41 и UBI18-35 для дифференциальной диагностики септического воспаления костей конечностей; Бюллетень экспериментальной биологии и медицины; Т. 170, № 10
Foilsithe / Cruthaithe: (2020)
Foilsithe / Cruthaithe: (2020)
Production of the recombinant antimicrobial peptide UBI18-35 in Escherichia coli; Protein Expression and Purification; Vol. 143
Foilsithe / Cruthaithe: (2018)
Foilsithe / Cruthaithe: (2018)
Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation; Molecules; Vol. 30, iss. 1
Foilsithe / Cruthaithe: (2025)
Foilsithe / Cruthaithe: (2025)
Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors; International Journal of Molecular Sciences; Vol. 26, iss. 21
Foilsithe / Cruthaithe: (2025)
Foilsithe / Cruthaithe: (2025)
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?; Pharmaceutics; Vol. 17, iss. 10
Foilsithe / Cruthaithe: (2025)
Foilsithe / Cruthaithe: (2025)
Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer; Theranostics; Vol. 13, iss. 14
Foilsithe / Cruthaithe: (2023)
Foilsithe / Cruthaithe: (2023)
The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8; Pharmaceutics; Vol. 17, iss. 8
Foilsithe / Cruthaithe: (2025)
Foilsithe / Cruthaithe: (2025)
99mTc-HMPAO-Labeled Autologous Leukocyte SPECT/CT for Diagnosis of Bacterial Endocarditis of the Prosthetic Pulmonary Conduit: A Clinical Case; Iranian Journal of Radiology; Vol. 14, iss. 1
Foilsithe / Cruthaithe: (2017)
Foilsithe / Cruthaithe: (2017)
Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3, for Imaging of HER2-Positive Breast Cancer; Cancers; Vol. 15 - iss. 12
Foilsithe / Cruthaithe: (2023)
Foilsithe / Cruthaithe: (2023)
Single-Photon Emission Computer Tomography Imaging of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Cancer Patients Using a Novel Peptide-Based Probe [99mTc]Tc-BQ0413 with Picomolar Affinity to PSMA: A Phase I/II Clinical Study; ACS Pharmacology & Translational Science; Vol. 8, iss. 3
Foilsithe / Cruthaithe: (2025)
Foilsithe / Cruthaithe: (2025)
Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3; Nuclear Medicine and Biology; Vol. 124-125
Foilsithe / Cruthaithe: (2023)
Foilsithe / Cruthaithe: (2023)
Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer; Pharmaceutics; Vol. 13, iss. 2
Foilsithe / Cruthaithe: (2021)
Foilsithe / Cruthaithe: (2021)
Preclinical Evaluation of a Novel High-Affinity Radioligand [ 99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA); International Journal of Molecular Sciences; Vol. 24 - iss.24
Foilsithe / Cruthaithe: (2023)
Foilsithe / Cruthaithe: (2023)
Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1; International Journal of Molecular Sciences; Vol. 21, iss. 9
Foilsithe / Cruthaithe: (2020)
Foilsithe / Cruthaithe: (2020)
Development of an automated unit for extraction-chromatographic separation of the 99Mo/99m Tc generator couple; Radiochemistry; Vol. 56, iss. 2
Foilsithe / Cruthaithe: (2014)
Foilsithe / Cruthaithe: (2014)
Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake; International Journal of Molecular Sciences; Vol. 22, iss. 5
Foilsithe / Cruthaithe: (2021)
Foilsithe / Cruthaithe: (2021)
Antimicrobial Peptides Methods and Protocols /
Foilsithe / Cruthaithe: (2010)
Foilsithe / Cruthaithe: (2010)
Antimicrobial Peptides Methods and Protocols /
Foilsithe / Cruthaithe: (2017)
Foilsithe / Cruthaithe: (2017)
Evaluation of the Functional Suitability of Carboxylate Chlorin e6 Derivatives for Use in Radionuclide Diagnostics; Pharmaceutics; Vol. 18, iss. 1
Foilsithe / Cruthaithe: (2026)
Foilsithe / Cruthaithe: (2026)
Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1; Molecules; Vol. 25, iss. 20
Foilsithe / Cruthaithe: (2020)
Foilsithe / Cruthaithe: (2020)
The diagnostic value of SPECT CZT quantitative myocardial blood flow in high-risk patients; Journal of Nuclear Cardiology; Vol. XXX
Foilsithe / Cruthaithe: (2020)
Foilsithe / Cruthaithe: (2020)
Reduction of Negative Charge in Mercaptoacetyl-Based Chelators Influences the Biodistribution of Prostate-Specific Membrane Antigen-Targeting Pseudopeptides Labeled with Technetium-99m; ACS Pharmacology & Translational Science; Vol. 8, iss. 10
Foilsithe / Cruthaithe: (2025)
Foilsithe / Cruthaithe: (2025)
Validation of an Analytical HPLC Method for a New Diagnostic Octreotide Derivative for Neuroendocrine Tumors; Pharmaceutical Chemistry Journal; Vol. 53, iss. 9
Foilsithe / Cruthaithe: (2019)
Foilsithe / Cruthaithe: (2019)
Разработка модели малогабаритного экстрактора с саморегулируемым уровнем границы раздела фаз для разделения пары 99Мо/99MТс; Известия Томского политехнического университета [Известия ТПУ]; Т. 323, № 3 : Химия
Foilsithe / Cruthaithe: (2013)
Foilsithe / Cruthaithe: (2013)
An investigation of calcium carbonate core-shell particles for incorporation of 225Ac and sequester of daughter radionuclides: in vitro and in vivo studies; Journal of Controlled Release; Vol. 330
Foilsithe / Cruthaithe: (2021)
Foilsithe / Cruthaithe: (2021)
Получение антимикробного пептида UBI[18-35] с использованием рекомбинантных технологий; Перспективы развития фундаментальных наук
de réir: Ащеулова Д. О. Дарья Олеговна
Foilsithe / Cruthaithe: (2015)
de réir: Ащеулова Д. О. Дарья Олеговна
Foilsithe / Cruthaithe: (2015)
Cyclotron Production of 99Mo Radionuclide by Bombarding Zirconium Targets with Alpha Particle Beams; Russian Physics Journal; Vol. 62, iss. 4
Foilsithe / Cruthaithe: (2019)
Foilsithe / Cruthaithe: (2019)
Получение нового наноколлоидного радиофармпрепарата на основе оксида алюминия; Известия Томского политехнического университета [Известия ТПУ]; Т. 323, № 3 : Химия
Foilsithe / Cruthaithe: (2013)
Foilsithe / Cruthaithe: (2013)
Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion; International Journal of Molecular Sciences; Vol. 25, iss. 8
Foilsithe / Cruthaithe: (2024)
Foilsithe / Cruthaithe: (2024)
99mTc-labeled monosaccharide kits: development methods and quality control; Scientific Reports; Vol. 10
Foilsithe / Cruthaithe: (2020)
Foilsithe / Cruthaithe: (2020)
99mTc-labeled nanocolloid drugs: development methods; Scientific Reports; Vol. 10, iss. 1
Foilsithe / Cruthaithe: (2020)
Foilsithe / Cruthaithe: (2020)
Cross section of the 96Zr(α,n)99Mo reaction induced by α-particles beams on natZr targets; Applied Radiation and Isotopes; Vol. 166
Foilsithe / Cruthaithe: (2020)
Foilsithe / Cruthaithe: (2020)
Получение рекомбинантного антимикробного пептида UBI 18-35 для дифференциальной диагностики воспалений; Химия и химическая технология в XXI веке
de réir: Ащеулова Д. О. Дарья Олеговна
Foilsithe / Cruthaithe: (2016)
de réir: Ащеулова Д. О. Дарья Олеговна
Foilsithe / Cruthaithe: (2016)
Limbes
de réir: Paul M. V.
Foilsithe / Cruthaithe: (Санкт-Петербург, Лань, 2014)
de réir: Paul M. V.
Foilsithe / Cruthaithe: (Санкт-Петербург, Лань, 2014)
The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99mTc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1; Molecular Pharmaceutics; Vol. 23, iss. 4
Foilsithe / Cruthaithe: (2026)
Foilsithe / Cruthaithe: (2026)
Optimal composition and position of histidine-containing tags improves biodistribution of 99mTc-labeled DARPin G3; Scientific Reports; Vol. 9
Foilsithe / Cruthaithe: (2019)
Foilsithe / Cruthaithe: (2019)
Изучение адсорбции 99mTC на оксиде алюминия; Радиохимия; № 5
Foilsithe / Cruthaithe: (2011)
Foilsithe / Cruthaithe: (2011)
Adsorption of 99mTc on aluminum oxide; Radiochemistry; Vol. 53, iss. 5
Foilsithe / Cruthaithe: (2011)
Foilsithe / Cruthaithe: (2011)
Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors; Cancers; Vol. 15 - iss. 6
Foilsithe / Cruthaithe: (2023)
Foilsithe / Cruthaithe: (2023)
Antimicrobial Therapies Methods and Protocols /
Foilsithe / Cruthaithe: (2021)
Foilsithe / Cruthaithe: (2021)
Míreanna comhchosúla
-
Радиохимический комплекс на основе меченных 99mТс антимикробных пептидов UBI29-41 и UBI18-35 для дифференциальной диагностики септического воспаления костей конечностей; Бюллетень экспериментальной биологии и медицины; Т. 170, № 10
Foilsithe / Cruthaithe: (2020) -
Production of the recombinant antimicrobial peptide UBI18-35 in Escherichia coli; Protein Expression and Purification; Vol. 143
Foilsithe / Cruthaithe: (2018) -
Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation; Molecules; Vol. 30, iss. 1
Foilsithe / Cruthaithe: (2025) -
Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors; International Journal of Molecular Sciences; Vol. 26, iss. 21
Foilsithe / Cruthaithe: (2025) -
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?; Pharmaceutics; Vol. 17, iss. 10
Foilsithe / Cruthaithe: (2025)